Clinical Ophthalmology, 2016 Hannu Uusitalo,1 Evgeniy Egorov,2 Kai Kaarniranta,3 Yuri Astakhov,4 Auli Ropo5 On behalf of the Switch Study Tafluprost Study Groups 1Department of Ophthalmology, SILK, University of Tampere, Tampere University Hospital, Tampere, Finland; 2Department ...
Uusitalo H +4 more
doaj +1 more source
Extended Latanoprost Release from Commercial Contact Lenses: In Vitro Studies Using Corneal Models [PDF]
, 2014 Mohammadi, S., Jones, L., & Gorbet, M. (2014). Extended Latanoprost Release from Commercial Contact Lenses: In Vitro Studies Using Corneal Models. PLoS ONE, 9(9), e106653.
Gorbet, Maud +2 more
core +5 more sources
Reliable intraocular pressure measurement using automated radio-wave telemetry [PDF]
, 2014 Purpose To present an autonomous intraocular pressure (IOP) measurement technique using a wireless implantable transducer (WIT) and a motion sensor. Methods: The WIT optical aid was implanted within the ciliary sulcus of a normotensive rabbit eye after ...
Cade, Fabiano +5 more
core +3 more sources
Episcleral Venous Pressure and the Ocular Hypotensive Effects of Topical and Intracameral Prostaglandin Analogs. [PDF]
, 2019 There is a limit beyond which increasing either the concentration of a prostaglandin analog (PGA) or its dosing frequency fails to produce increases in ocular hypotensive efficacy with topical dosing.
Alm +36 more
core +2 more sources
Peripheral Latanoprost Administration Lowers Intraocular Pressure in the Wistar Rat
Ophthalmology and Therapy, 2020 Purpose Instillation of latanoprost eye drops into the conjunctival sac to lower intraocular pressure (IOP) is the most frequently used treatment for primary open-angle glaucoma.
Maciej Świątkiewicz +5 more
doaj +1 more source
Pharmaceuticals, 2022 To compare the efficacy, patient-reported satisfaction, and safety of preservative-free (PF)-tafluprost, PF-dorzolamide/timolol and preservative-containing (P)-latanoprost in Korean glaucoma patients with ocular surface disease (OSD).
Sang-Woo Park +2 more
doaj +1 more source
Tear cytokine profile of glaucoma patients treated with preservative-free or preserved latanoprost [PDF]
, 2017 Purpose: To determine variations in cytokine levels of glaucoma patients treated either with preservative-free latanoprost or preserved latanoprost, relative to healthy individuals.
Arriola Villalobos, Pedro +7 more
core +2 more sources
Long-term cost and efficacy analysis of latanoprost versus timolol in glaucoma patients in Germany
International Journal of Ophthalmology, 2013 AIM: To evaluate 5-year effectiveness and cost between latanoprost or timolol monotherapy in a pilot trial. METHODS: A retrospective, multi-center trial performed at 6 sites in Germany of patients who had a diagnosis of primary open-angle or ...
Jeanette A. Stewart +6 more
doaj +1 more source
Comparative study of the stability of bimatoprost 0.03% and latanoprost 0.005%: A patient-use study
BMC Ophthalmology, 2008 Background The stability of ophthalmic preparations in multidose containers is influenced by the preservative as well as the stability of the active ingredient.
Umbelino Cristiano C +3 more
doaj +1 more source
Twenty-four hour efficacy with preservative free tafluprost compared with latanoprost in patients with primary open angle glaucoma or ocular hypertension [PDF]
, 2013 10openopenKonstas A.G.; Quaranta L.; Katsanos A.; Riva I.; Tsai J.C.; Giannopoulos T.; Voudouragkaki I.C.; Paschalinou E.; Floriani I.; Haidich A.B.Konstas, A. G.; Quaranta, Luciano; Katsanos, A.; Riva, Ivano; Tsai, J. C.; Giannopoulos, T.; Voudouragkaki,
Konstas A.G. +9 more
core +1 more source